EYPT Historical Earnings image   This EYPT historical earnings page last updated 11/4/2022
EYPT Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202211/2/20220.01B
Q2 20228/3/20220.01B
Q1 20225/4/20220.01B
Q4 20213/3/20220.01B
Q3 202111/3/20210.01B
Q2 20218/4/20210.01B
Q1 20215/5/20210.01B
Q4 20203/4/20210.01B
Q3 202011/5/20200.02B
Q2 20208/5/20200.00B
Q1 20205/6/20200.01B
Q4 20193/5/20200.01B
Q3 201911/7/20190.00B
Q2 20198/7/20190.01B
Q1 20195/8/20190.00B
Q2 20193/14/2019742000
Q1 201911/6/2018486000
Q4 20189/12/2018715000
Q3 20185/8/2018928000
Q2 20182/7/2018933000
Q1 201811/7/2017385000
Q4 20179/11/2017701000
Q3 20175/4/2017590000
Q2 20172/7/2017371000
Q1 201711/7/2016277000
Q4 20169/12/2016304000
Q3 20165/5/2016324000
Q2 20162/8/2016526000
Q1 201611/5/2015466000
Q4 20159/9/2015409000
Q3 20155/8/2015328000
Q2 20152/5/2015521000
Q1 201511/7/201425.30M
Q4 20149/9/2014292000
Q3 20145/13/20142.00M
Q2 20142/7/2014590000
Q1 201411/12/2013597000
Q4 20139/25/2013492000
Q3 20135/13/2013513000
Q2 20132/6/2013585000
Q1 201311/8/2012553000
Q4 20129/24/2012700000
EYPT Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q3 202211/2/2022-0.490
Q2 20228/3/2022-0.520
Q1 20225/4/2022-0.560
Q4 20213/3/2022-0.590
Q3 202111/3/2021-0.580
Q2 20218/4/2021-0.420
Q1 20215/5/2021-0.500
Q4 20203/4/2021-1.000
Q3 202011/5/2020-0.300
Q2 20208/5/2020-1.000
Q1 20205/6/2020-1.100
Q4 20193/5/2020-1.000
Q3 201911/7/2019-1.500
Q2 20198/7/2019-1.100
Q1 20195/8/2019-2.000
Q2 20193/14/2019-1.200
Q1 201911/6/2018-4.400
Q4 20189/12/2018-6.200
Q3 20185/8/2018-1.500
Q2 20182/7/2018-1.300
Q1 201811/7/2017-1.500
Q4 20179/11/2017-1.600
Q3 20175/4/2017-0.15
Q2 20172/7/2017-1.600
Q1 201711/7/2016-2.100
Q4 20169/12/2016-1.900
Q3 20165/5/2016-1.500
Q2 20162/8/2016-1.800
Q1 201611/5/2015-1.700
Q4 20159/9/2015-1.700
Q3 20155/8/2015-1.700
Q2 20152/5/2015-1.400
Q1 201511/7/20146.700
Q4 20149/9/2014-1.400
Q3 20145/13/2014-0.800
Q2 20142/7/2014-1.300
Q1 201411/12/2013-1.400
Q4 20139/25/2013-1.700
Q3 20135/13/2013-1.200
Q2 20132/6/2013-1.100
Q1 201311/8/2012-1.100
Q4 20129/24/2012-1.100
Quotes delayed 20 minutes

Email EnvelopeFree EYPT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
EyePoint Pharmaceuticals (EYPT) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

FATE Historical Earnings
FBIO Historical Earnings
FBRX Historical Earnings
FDMT Historical Earnings
FEMY Historical Earnings
FGEN Historical Earnings
FHTX Historical Earnings
FIXX Historical Earnings
FLDM Historical Earnings
FLGT Historical Earnings
What was the record high EYPT historical earnings result?
In terms of earnings or revenue, what is the best EYPT historical earnings result that EyePoint Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest EYPT historical earnings result was set in Q1 2015, when EyePoint Pharmaceuticals posted results of 6.700/share. The most successful revenue quarter within our data set was Q1 2015 when EyePoint Pharmaceuticals reported revenue of 25.30M.

What was the lowest EyePoint Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest EYPT has reported, and when?

✔️Accepted answer: Within our data set, the lowest EYPT historical earnings result was set in Q4 2018, when EyePoint Pharmaceuticals posted results of -6.200/share. The smallest revenue quarter within our data set was Q1 2017 when EyePoint Pharmaceuticals reported revenue of 277000.

On this page we presented the EYPT historical earnings date information for EyePoint Pharmaceuticals. Reviewing that EYPT Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q1 2015, when EYPT posted gaap of 6.700/share. Meanwhile the lowest EYPT historical earnings result was in Q4 2018, when EYPT posted gaap of -6.200/share. Moving to EyePoint Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q1 2015 when EYPT reported 25.30M in revenue, while the smallest revenue quarter was Q1 2017 when EYPT reported 277000 in revenue.

For self directed investors doing their due diligence on EYPT or any other given stock, their research can benefit from looking into all of the EyePoint Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into EyePoint Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for EYPT. Thanks for visiting, and the next time you need to research EYPT historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: LEU Split History, IPAC market cap history, BPMP Stock Predictions.

 

EYPT Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.